Hepatitis A is a viral and highly contagious liver infection caused by the hepatitis A virus. Hepatitis A virus is spread primarily by the fecal-oral route. Hepatitis A virus transmission can occur by consuming food prepared by an infected person, drinking contaminated water, having close personal contact with a person who has the disease.
Risk factors that may increase the possibility of having hepatitis A include, travel internationally, providing care in a nursing home center, using illegal drugs, and Sexual intercourse with an infected person. Signs and symptoms of hepatitis A, include abdominal pain or discomfort, Jaundice, nausea, and vomiting. Number of research that exploring the pathogenesis of hepatitis A infections has been remarkably decreased after the discovery of hepatitis A vaccine.
Diagnostic steps to investigate hepatitis A may include, reviewing the medical history, performing a physical examination, and blood tests. There is no available cure or antiviral for hepatitis A. The human body is able eventually to get rid of the infection on its own. Coping techniques to cope with hepatitis A include plenty of rest and using of painkillers.
To prevent hepatitis A, some measures can be suggested, including vaccination, good personal hygiene, and adopting safety precautions when visiting other countries. The most cases of hepatitis A will recover within two months and there will be no long-term complications.
Hepatitis A is a viral and highly contagious liver infection caused by the hepatitis A virus. Hepatitis A infection does not cause chronic liver disease and is rarely fatal. Hepatitis A, hepatitis B, and hepatitis C are caused by different viruses, spread in different ways, and require different interventions. Hepatitis A is the least serious and mildest of these liver infections.
Hepatitis A virus (HAV) is classified in the genus Hepatovirus within the family Picornaviridae, and it is characterized as a small, nonenveloped hepatotropic virus.
6 different genotypes (I to VI) of hepatitis A have been investigated in the literature. The human genotypes are I, II and III, the other genotypes (IV, V, and VI) are simian genotypes. Genotypes I to III are further subdivided into distinct groups (A and B).The most frequently reported genotype among humans is genotype I. Although more investigations are required, some studies indicate severe clinical manifestations coincide with some of these genotypes.
Hepatitis A is caused by a virus and spread primarily by the fecal-oral route. Hepatitis A virus transmission can occur by:
It is important to mention that a baby cannot get hepatitis A by breastfeeding. Moreover, hugging or sitting next to an infected person does not transmit the virus to a healthy person; also, coughing or sneezing does not spread the virus.
There are several risk factors that may increase the possibility of contracting the virus, include:
Since the development of hepatitis A vaccine almost 2 decades ago, the motivation to conduct research exploring the pathogenesis of hepatitis A infections and how the infection is cleared from the liver has been decreased.
Hepatitis A is transmitted by fecal-oral route and replicates in the liver. The replication of the virus depends on hepatocyte uptake. After the uptake occurs, the viral RNA is uncoated and host ribosomes bind to make up polysomes. Soon after that, the viral proteins can then be synthesized by copying of viral genome by a viral RNA polymerase.
Hepatitis A virus can reach the blood and, is excreted by the biliary system into the faces 10-12 days after the infection. Hepatitis A virus’s concentration is quite high in faces than it is in the serum. However, a significant decline in hepatitis A virus excretion 7-10 days after onset of symptoms has been observed. By the third week of illness, the majority of infected persons no longer excrete virus in the feces.
Hepatitis B shares a number of features with hepatitis A, such as being positive-strand RNA virus, along with other features that relate to replication mechanisms include the production of double-stranded RNA and potent induction of innate immune responses during the replication of the genomes by cytoplasmic membrane-bound replicase complexes. Moreover, both viruses use similar disruption strategies against the early innate immune responses.
Symptoms of hepatitis A may not appear in many people who are infected with the disease.Signs and symptoms of hepatitis A may include:
In general, symptoms of hepatitis A tend to be milder in children. The severity of hepatitis A symptoms increases as age advances.
Physicians are usually examining symptoms and recommending blood tests to diagnose the disease. Diagnostic steps to investigate hepatitis A may include:
Additional tests may be suggested to detect hepatitis A virus RNA, such as RT-PCR (reverse transcriptase polymerase chain reaction).
There is no available cure or antiviral for hepatitis A. The human body is able eventually to get rid of the infection on its own. Coping techniques that may help infected persons with hepatitis A may include:
It is rare to see any complications caused by hepatitis A and it is improbable to cause a long-term liver damage, and it does not progress to be chronic.
Most cases of hepatitis A show full recovery within two months without developing permanent liver damage.
Some of the preventive measures concerning hepatitis A include:
The hepatitis A vaccine is given in two doses. The second dose should be given 6 to 12 months after the first shot. Taking both shots is important to provide full protection against the virus.
The most cases of hepatitis A recover within two months and there will be no long-term complications. The patient normally develops life-long immunity against the virus and the virus does not remain in the body after the infection is gone.
In some cases, symptoms may appear and disappear for up to 6 months before eventually go away and the risk of death is so low, but, the risk remains higher among people who suffer from long-term liver disease and among older adults.